Drug Shortage Report for DIGIFAB
| Report ID | 192243 |
| Drug Identification Number | 02361043 |
| Brand name | DIGIFAB |
| Common or Proper name | Digoxin Immune Fab (ovine) |
| Company Name | BTG INTERNATIONAL INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DIGOXIN IMMUNE FAB |
| Strength(s) | 40MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | One vial |
| ATC code | V03AB |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2023-05-10 |
| Estimated end date | 2024-01-12 |
| Actual end date | 2024-01-12 |
| Shortage status | Resolved |
| Updated date | 2024-01-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 300 FOUR FALLS CORPORATE CENTER, 300 CONSHOHOCKEN STATE ROAD WEST CONSHOHOCKEN, PENNSYLVANIA UNITED STATES 19428 |
| Company contact information | samuel.jenkinson@btgsp.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2024-01-16 | French | Compare |
| v9 | 2024-01-16 | English | Compare |
| v8 | 2023-11-30 | French | Compare |
| v7 | 2023-11-30 | English | Compare |
| v6 | 2023-08-09 | French | Compare |
| v5 | 2023-08-09 | English | Compare |
| v4 | 2023-05-12 | French | Compare |
| v3 | 2023-05-12 | English | Compare |
| v2 | 2023-05-12 | English | Compare |
| v1 | 2023-05-11 | English | Compare |
Showing 1 to 10 of 10